SB772077B is a selective inhibitor of Rho-associated protein kinase (ROCK), primarily targeting the RhoA/ROCK signaling pathway. This compound exhibits anti-inflammatory properties and enhances aqueous outflow facility, making it relevant for research in glaucoma. Additionally, SB772077B reduces mRNA levels of β-catenin and proteins associated with fibrosis, such as vinculin, fibronectin, collagen 1A, and vimentin. Furthermore, it demonstrates vasodilatory effects and lowers both pulmonary and systemic blood pressure, contributing to its utility in studies related to pulmonary hypertensive disorders.
SB772077B is a selective inhibitor of Rho-associated protein kinase (ROCK), primarily targeting the RhoA/ROCK signaling pathway. This compound exhibits anti-inflammatory properties and enhances aqueous outflow facility, making it relevant for research in glaucoma. Additionally, SB772077B reduces mRNA levels of β-catenin and proteins associated with fibrosis, such as vinculin, fibronectin, collagen 1A, and vimentin. Furthermore, it demonstrates vasodilatory effects and lowers both pulmonary and systemic blood pressure, contributing to its utility in studies related to pulmonary hypertensive disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
